Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Charles Quick

Concepts (404)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Endometrial Neoplasms
18
2021
138
4.560
Why?
Uterine Neoplasms
10
2023
60
1.980
Why?
Carcinoma in Situ
7
2022
73
1.980
Why?
Vulvar Neoplasms
5
2022
52
1.920
Why?
Carcinoma, Endometrioid
6
2021
38
1.640
Why?
Adenocarcinoma
10
2024
396
1.590
Why?
Carcinoma, Squamous Cell
8
2019
318
1.480
Why?
PAX2 Transcription Factor
7
2015
22
1.460
Why?
Uterine Cervical Neoplasms
7
2024
277
1.200
Why?
Ovarian Neoplasms
10
2024
447
1.190
Why?
Endometrial Hyperplasia
4
2019
14
1.150
Why?
Stromal Cells
2
2016
72
1.040
Why?
Sarcoma, Alveolar Soft Part
1
2023
1
0.910
Why?
Cannabidiol
5
2024
37
0.890
Why?
Female
65
2024
26472
0.880
Why?
Myometrium
2
2013
14
0.870
Why?
Endometrium
6
2023
41
0.840
Why?
Adenocarcinoma, Clear Cell
6
2019
34
0.790
Why?
Precancerous Conditions
3
2019
83
0.760
Why?
Aged, 80 and over
20
2024
3129
0.740
Why?
Cystadenocarcinoma, Serous
4
2013
70
0.700
Why?
Plant Extracts
5
2024
190
0.690
Why?
Tumor Suppressor Protein p53
2
2017
202
0.660
Why?
Humans
68
2024
49974
0.650
Why?
Middle Aged
34
2024
12069
0.630
Why?
Peripheral Nerves
2
2015
49
0.630
Why?
Aged
29
2024
9310
0.600
Why?
Mutation
9
2024
1294
0.600
Why?
Placenta
6
2021
132
0.580
Why?
Epithelial-Mesenchymal Transition
2
2016
47
0.570
Why?
Cervix Uteri
2
2017
49
0.570
Why?
Adult
31
2024
13236
0.570
Why?
Immunohistochemistry
15
2020
973
0.560
Why?
Adenosarcoma
1
2016
3
0.560
Why?
Cannabis
5
2024
145
0.550
Why?
Polyps
1
2016
21
0.540
Why?
Uterine Cervical Dysplasia
1
2016
49
0.530
Why?
Lymphatic Metastasis
6
2019
224
0.510
Why?
Tumor Microenvironment
4
2021
212
0.510
Why?
Neoplasm Staging
9
2024
740
0.510
Why?
Fibroma
1
2015
39
0.510
Why?
Fallopian Tubes
2
2012
22
0.510
Why?
Prognosis
11
2024
1942
0.460
Why?
Neoplasm Invasiveness
6
2019
267
0.450
Why?
Pelvic Neoplasms
1
2011
14
0.400
Why?
Uterus
3
2023
94
0.390
Why?
Lymphocytes, Tumor-Infiltrating
3
2021
78
0.390
Why?
Ejaculatory Ducts
1
2010
3
0.360
Why?
Seminal Vesicles
1
2010
13
0.360
Why?
Neoplasm Recurrence, Local
4
2015
614
0.360
Why?
Spectrum Analysis, Raman
2
2021
58
0.350
Why?
Prostate
1
2010
117
0.340
Why?
Bromcresol Purple
1
2009
3
0.340
Why?
Electrophoresis, Capillary
1
2009
11
0.330
Why?
Serum Albumin
1
2009
58
0.330
Why?
Mice, Inbred C57BL
6
2024
1816
0.320
Why?
Human papillomavirus 16
2
2021
44
0.320
Why?
Methionine
2
2020
135
0.310
Why?
beta Catenin
2
2021
102
0.310
Why?
Disease Progression
4
2020
825
0.310
Why?
Mice
15
2024
5739
0.300
Why?
Diabetes Mellitus
2
2023
285
0.300
Why?
Papillomavirus Infections
2
2022
155
0.300
Why?
Papillomavirus Vaccines
2
2021
61
0.300
Why?
Genital Neoplasms, Female
2
2018
41
0.300
Why?
Anus Neoplasms
2
2018
24
0.300
Why?
Metaplasia
2
2019
16
0.290
Why?
Cell Proliferation
4
2021
1007
0.290
Why?
Antigens, CD
2
2019
219
0.280
Why?
Diagnosis, Differential
8
2020
1037
0.280
Why?
Prostatic Neoplasms
1
2010
394
0.270
Why?
Colitis
2
2020
50
0.270
Why?
Polyethylene Glycols
2
2017
93
0.270
Why?
Melanoma
2
2020
285
0.260
Why?
Neoplasm Grading
5
2021
123
0.260
Why?
Hypertension
2
2021
533
0.260
Why?
Chi-Square Distribution
2
2016
280
0.250
Why?
Gold
2
2017
136
0.250
Why?
Nanoparticles
2
2017
145
0.250
Why?
Proteomics
3
2017
329
0.240
Why?
Young Adult
7
2024
3958
0.240
Why?
Aspartic Acid Endopeptidases
2
2015
16
0.240
Why?
Racemases and Epimerases
2
2015
15
0.240
Why?
Retrospective Studies
11
2020
6108
0.240
Why?
Sex Cord-Gonadal Stromal Tumors
1
2024
3
0.240
Why?
Head and Neck Neoplasms
2
2019
268
0.230
Why?
Neuroendocrine Tumors
1
2024
23
0.230
Why?
Animals
16
2024
13187
0.230
Why?
Carcinoma, Neuroendocrine
1
2024
24
0.230
Why?
DNA Mutational Analysis
3
2024
175
0.230
Why?
Basic Helix-Loop-Helix Transcription Factors
1
2024
40
0.230
Why?
Kidney Neoplasms
2
2018
177
0.220
Why?
Homeodomain Proteins
1
2024
80
0.220
Why?
Chlamydia muridarum
1
2024
41
0.220
Why?
Lung Neoplasms
2
2019
606
0.220
Why?
Endometriosis
1
2023
14
0.220
Why?
Gynecology
2
2020
49
0.220
Why?
Chlamydia Infections
1
2024
77
0.220
Why?
Adenocarcinoma, Sebaceous
1
2022
7
0.210
Why?
Sebaceous Gland Neoplasms
1
2022
16
0.210
Why?
Observer Variation
3
2017
130
0.210
Why?
CD4-Positive T-Lymphocytes
1
2024
164
0.210
Why?
Fallopian Tube Neoplasms
2
2012
14
0.210
Why?
Immunotherapy
2
2021
238
0.200
Why?
Gestational Trophoblastic Disease
2
2012
2
0.200
Why?
CTLA-4 Antigen
1
2021
25
0.200
Why?
Genotype
2
2021
537
0.200
Why?
Fetal Membranes, Premature Rupture
1
2021
22
0.190
Why?
Oncogene Fusion
1
2021
4
0.190
Why?
PTEN Phosphohydrolase
3
2020
55
0.190
Why?
Estrogens
2
2023
227
0.190
Why?
Leiomyosarcoma
1
2021
23
0.190
Why?
Transcription Factors
3
2020
561
0.190
Why?
Diabetes, Gestational
1
2021
53
0.190
Why?
Cancer Vaccines
1
2021
78
0.190
Why?
Carcinosarcoma
2
2017
18
0.180
Why?
Infant, Small for Gestational Age
1
2020
34
0.180
Why?
Carcinoma, Papillary
1
2020
48
0.180
Why?
Neoplasms, Experimental
1
2020
114
0.180
Why?
Carcinoma, Transitional Cell
1
2020
52
0.180
Why?
Colonic Neoplasms
1
2021
161
0.170
Why?
Pregnancy in Diabetics
1
2020
31
0.170
Why?
Dermatology
1
2020
49
0.170
Why?
Carcinoma, Signet Ring Cell
1
2019
14
0.170
Why?
Pregnancy Complications, Neoplastic
1
2019
22
0.170
Why?
Carcinoma, Lewis Lung
1
2019
10
0.170
Why?
Placenta Diseases
1
2019
14
0.170
Why?
Radiotherapy
1
2020
128
0.170
Why?
Carcinoma, Renal Cell
2
2018
105
0.170
Why?
Skin Diseases
1
2020
112
0.170
Why?
Hepatic Veno-Occlusive Disease
1
2019
10
0.170
Why?
Premature Birth
1
2021
147
0.170
Why?
Odds Ratio
3
2015
545
0.170
Why?
Hodgkin Disease
1
2019
44
0.170
Why?
DNA Polymerase II
1
2019
9
0.170
Why?
Melanoma, Experimental
1
2019
45
0.170
Why?
DNA Mismatch Repair
1
2019
17
0.170
Why?
Inflammation
2
2020
604
0.170
Why?
Fetal Diseases
1
2019
62
0.170
Why?
T-Lymphocytes
1
2021
338
0.170
Why?
Sarcoma
1
2020
67
0.160
Why?
Monocytes
1
2019
131
0.160
Why?
Urinary Bladder Neoplasms
1
2020
155
0.160
Why?
Reproducibility of Results
4
2017
1193
0.160
Why?
Metformin
1
2020
64
0.160
Why?
Pregnancy
7
2021
2607
0.160
Why?
Methionine Adenosyltransferase
1
2018
19
0.160
Why?
CD8-Positive T-Lymphocytes
1
2019
116
0.160
Why?
Logistic Models
3
2015
888
0.160
Why?
Nuclear Proteins
1
2020
242
0.160
Why?
Hypoglycemic Agents
1
2020
168
0.160
Why?
Radiation Tolerance
1
2019
85
0.160
Why?
Disease Models, Animal
6
2020
1455
0.150
Why?
Neural Cell Adhesion Molecule L1
1
2017
1
0.150
Why?
Rhabdomyosarcoma
1
2018
13
0.150
Why?
Programmed Cell Death 1 Receptor
1
2018
38
0.150
Why?
DNA Helicases
1
2020
143
0.150
Why?
Pathology, Molecular
1
2017
22
0.150
Why?
Hepatocytes
1
2019
182
0.150
Why?
Proto-Oncogene Proteins p21(ras)
1
2018
66
0.150
Why?
Intestinal Mucosa
2
2020
225
0.150
Why?
Biopsy
5
2020
584
0.150
Why?
Tumor Necrosis Factor-alpha
2
2019
388
0.150
Why?
Liver
3
2024
1115
0.150
Why?
Cyclin-Dependent Kinase Inhibitor p16
1
2017
55
0.150
Why?
Pregnancy Complications
1
2021
382
0.140
Why?
Osteosarcoma
1
2017
47
0.140
Why?
Neoplastic Cells, Circulating
1
2017
74
0.140
Why?
Vimentin
1
2016
32
0.140
Why?
Gene Expression Profiling
2
2019
1032
0.140
Why?
Papillomaviridae
1
2017
102
0.140
Why?
Time Factors
3
2021
2903
0.140
Why?
Acetaminophen
1
2019
283
0.140
Why?
Oligonucleotide Array Sequence Analysis
1
2017
411
0.140
Why?
DNA-Binding Proteins
2
2016
427
0.140
Why?
Cadherins
1
2016
68
0.130
Why?
Viral Load
1
2016
76
0.130
Why?
Hepatocyte Nuclear Factor 1-beta
1
2015
5
0.130
Why?
Skin Neoplasms
1
2020
488
0.130
Why?
Neoplasms, Muscle Tissue
1
2015
12
0.130
Why?
Malate Dehydrogenase
1
2014
8
0.120
Why?
Classification
1
2015
14
0.120
Why?
Colposcopy
1
2015
18
0.120
Why?
Class I Phosphatidylinositol 3-Kinases
3
2024
18
0.120
Why?
Lipogenesis
1
2014
29
0.120
Why?
World Health Organization
1
2015
48
0.120
Why?
Flow Cytometry
1
2017
476
0.120
Why?
Cytosol
1
2014
82
0.120
Why?
Mice, Inbred BALB C
3
2021
304
0.120
Why?
Adolescent
4
2024
6356
0.120
Why?
Neoplasm, Residual
1
2015
165
0.120
Why?
Mammary Neoplasms, Experimental
1
2015
122
0.120
Why?
Histones
1
2016
312
0.120
Why?
Obesity
1
2022
1113
0.120
Why?
Multiple Myeloma
1
2009
2929
0.120
Why?
High-Throughput Nucleotide Sequencing
3
2021
169
0.120
Why?
Antineoplastic Agents
2
2021
1171
0.120
Why?
Gastrointestinal Tract
1
2014
103
0.110
Why?
Male
10
2024
25241
0.110
Why?
Intestines
1
2014
176
0.110
Why?
Oncogenes
1
2013
57
0.110
Why?
Patient Selection
1
2015
253
0.110
Why?
Cell Line, Tumor
4
2020
1403
0.110
Why?
Clusterin
1
2012
6
0.110
Why?
Predictive Value of Tests
4
2018
903
0.110
Why?
Membrane Proteins
1
2015
341
0.110
Why?
Pancreatic Neoplasms
1
2015
208
0.110
Why?
Risk Factors
3
2015
3613
0.110
Why?
Histocytochemistry
1
2012
44
0.100
Why?
Receptors, Vascular Endothelial Growth Factor
1
2012
22
0.100
Why?
Strongyloidiasis
1
2012
10
0.100
Why?
Follow-Up Studies
2
2016
2182
0.100
Why?
Treatment Outcome
3
2021
5141
0.100
Why?
Cytomegalovirus Infections
1
2012
34
0.100
Why?
Prednisone
1
2012
99
0.100
Why?
Tissue Inhibitor of Metalloproteinases
1
2011
11
0.100
Why?
Vascular Endothelial Growth Factor A
1
2012
201
0.100
Why?
Teratoma
1
2011
25
0.100
Why?
Matrix Metalloproteinases
1
2011
48
0.100
Why?
Sensitivity and Specificity
3
2020
861
0.090
Why?
Adenoma, Oxyphilic
1
2010
11
0.090
Why?
Image Processing, Computer-Assisted
1
2012
242
0.090
Why?
Phenotype
3
2019
729
0.090
Why?
Tissue Array Analysis
3
2015
45
0.090
Why?
Glucocorticoids
1
2012
219
0.090
Why?
Tumor Cells, Cultured
2
2021
465
0.090
Why?
Epigenesis, Genetic
1
2012
374
0.080
Why?
Pregnancy Outcome
2
2021
237
0.080
Why?
Pilot Projects
2
2023
699
0.080
Why?
Phosphatidylinositol 3-Kinases
2
2024
141
0.080
Why?
Infant, Newborn
3
2021
2772
0.080
Why?
Telemedicine
1
2015
448
0.080
Why?
Necrosis
2
2024
176
0.080
Why?
Cell Differentiation
2
2024
651
0.080
Why?
Hysterectomy
2
2021
88
0.080
Why?
Cell Nucleus
2
2021
183
0.080
Why?
Societies, Medical
2
2019
175
0.080
Why?
Host-Pathogen Interactions
2
2021
134
0.070
Why?
Neoplasms
1
2017
1235
0.070
Why?
Gene Expression Regulation
3
2023
976
0.070
Why?
Consensus
2
2020
148
0.070
Why?
Ventricular Pressure
1
2006
15
0.070
Why?
Isoproterenol
1
2006
56
0.070
Why?
Terminology as Topic
2
2018
62
0.070
Why?
Kaplan-Meier Estimate
2
2018
466
0.070
Why?
Serum Response Factor
1
2006
42
0.070
Why?
Kidney
1
2010
665
0.070
Why?
Combined Modality Therapy
2
2020
637
0.070
Why?
Practice Guidelines as Topic
2
2019
449
0.070
Why?
Neoplasm Metastasis
2
2018
231
0.060
Why?
Cytokines
2
2020
612
0.060
Why?
Cells, Cultured
2
2021
1573
0.060
Why?
Proportional Hazards Models
2
2017
402
0.060
Why?
Chromatography, Liquid
2
2016
232
0.060
Why?
Bilirubin
1
2024
40
0.060
Why?
Tandem Mass Spectrometry
2
2016
236
0.060
Why?
Species Specificity
1
2024
192
0.060
Why?
Dose-Response Relationship, Drug
2
2019
1376
0.060
Why?
Heart
1
2006
326
0.060
Why?
Steroids
1
2024
57
0.060
Why?
Th1 Cells
1
2024
52
0.060
Why?
Interleukin-10
1
2024
84
0.060
Why?
Phylogeny
1
2024
235
0.060
Why?
Gene Expression Regulation, Neoplastic
2
2018
828
0.050
Why?
Government Agencies
1
2022
14
0.050
Why?
Receptors, Cytoplasmic and Nuclear
1
2023
64
0.050
Why?
Hemorrhage
1
2024
197
0.050
Why?
Choriocarcinoma
2
2012
7
0.050
Why?
Genes, T-Cell Receptor
1
2021
5
0.050
Why?
Uterine Hemorrhage
1
2021
11
0.050
Why?
Clinical Trials, Phase I as Topic
1
2021
25
0.050
Why?
Parturition
1
2021
49
0.050
Why?
Phthalazines
1
2021
20
0.050
Why?
Remission Induction
1
2021
207
0.050
Why?
Quinazolines
1
2021
33
0.050
Why?
Lymphocyte Activation
1
2021
172
0.050
Why?
Vulva
1
2020
17
0.050
Why?
Taurine
1
2020
15
0.050
Why?
Research Report
1
2020
16
0.050
Why?
Metabolic Networks and Pathways
1
2021
89
0.050
Why?
Herb-Drug Interactions
1
2020
31
0.050
Why?
Mucin-2
1
2020
7
0.050
Why?
Toxicity Tests
1
2020
52
0.050
Why?
Alkaline Phosphatase
1
2020
94
0.040
Why?
Molecular Targeted Therapy
1
2021
119
0.040
Why?
Risk
1
2021
320
0.040
Why?
Piperazines
1
2021
117
0.040
Why?
Chemokines
1
2020
77
0.040
Why?
United States
3
2016
4860
0.040
Why?
Birth Weight
1
2020
120
0.040
Why?
Preoperative Period
1
2020
46
0.040
Why?
Chorionic Villi
1
2019
3
0.040
Why?
Kruppel-Like Transcription Factors
1
2020
36
0.040
Why?
Reverse Transcriptase Polymerase Chain Reaction
2
2014
595
0.040
Why?
Endothelium
1
2019
39
0.040
Why?
Colon
1
2020
98
0.040
Why?
Pyrimidines
1
2021
192
0.040
Why?
Chest Pain
1
2019
53
0.040
Why?
Receptors, Progesterone
1
2020
63
0.040
Why?
Ultrasonography, Doppler, Color
1
2019
33
0.040
Why?
Mice, Transgenic
2
2014
555
0.040
Why?
Intercellular Adhesion Molecule-1
1
2019
63
0.040
Why?
Cytochrome P-450 Enzyme System
1
2020
195
0.040
Why?
Glutamine
1
2020
171
0.040
Why?
Dyspnea
1
2019
74
0.040
Why?
Estrogen Receptor alpha
1
2020
89
0.040
Why?
Liver Function Tests
1
2019
47
0.040
Why?
Fatal Outcome
1
2019
195
0.040
Why?
Mice, Inbred Strains
1
2019
161
0.040
Why?
Drug Synergism
1
2019
150
0.040
Why?
Imaging, Three-Dimensional
1
2019
151
0.040
Why?
Gestational Age
1
2020
421
0.040
Why?
Mice, Nude
1
2019
252
0.040
Why?
Xenograft Model Antitumor Assays
1
2019
211
0.040
Why?
Mullerian Ducts
1
2018
4
0.040
Why?
Nephrectomy
1
2018
83
0.040
Why?
Wolffian Ducts
1
2018
2
0.040
Why?
Mutation Rate
1
2018
36
0.040
Why?
Lymph Node Excision
1
2019
134
0.040
Why?
Cell Lineage
1
2018
83
0.040
Why?
Mixed Tumor, Mullerian
1
2017
3
0.040
Why?
Ultrasonography, Prenatal
1
2019
188
0.040
Why?
Skin
1
2020
409
0.040
Why?
DNA Copy Number Variations
1
2018
110
0.040
Why?
Anal Canal
1
2017
21
0.040
Why?
Macrophages
1
2019
363
0.040
Why?
Dietary Supplements
1
2020
443
0.040
Why?
Transcriptome
1
2019
315
0.040
Why?
Matrix Attachment Region Binding Proteins
1
2017
34
0.040
Why?
Lymph Nodes
1
2019
260
0.040
Why?
Disease-Free Survival
1
2017
454
0.040
Why?
Child
2
2024
6847
0.040
Why?
Telomerase
1
2016
27
0.030
Why?
Vaccines, Subunit
1
2016
15
0.030
Why?
Ontario
1
2016
49
0.030
Why?
Mesonephros
1
2016
1
0.030
Why?
Diet
1
2020
566
0.030
Why?
Signal Transduction
1
2023
1618
0.030
Why?
Anion Exchange Protein 1, Erythrocyte
1
2015
8
0.030
Why?
T-Lymphocytes, Regulatory
1
2016
86
0.030
Why?
Extracellular Fluid
1
2015
15
0.030
Why?
Antiporters
1
2015
19
0.030
Why?
Leukocytes, Mononuclear
1
2016
116
0.030
Why?
S100 Proteins
1
2015
34
0.030
Why?
Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization
1
2015
63
0.030
Why?
Cell Count
1
2015
147
0.030
Why?
Cell Hypoxia
1
2015
82
0.030
Why?
Pressure
1
2015
105
0.030
Why?
Drug Evaluation, Preclinical
1
2015
144
0.030
Why?
Blood Vessels
1
2015
72
0.030
Why?
Receptor Protein-Tyrosine Kinases
1
2015
51
0.030
Why?
Genetic Predisposition to Disease
1
2018
510
0.030
Why?
Random Allocation
1
2015
281
0.030
Why?
Immunoenzyme Techniques
1
2014
143
0.030
Why?
Prospective Studies
1
2020
2364
0.030
Why?
Radiotherapy Dosage
1
2015
244
0.030
Why?
Apoptosis
1
2020
1101
0.030
Why?
Proteome
1
2016
173
0.030
Why?
Real-Time Polymerase Chain Reaction
1
2014
181
0.030
Why?
Likelihood Functions
1
2014
53
0.030
Why?
Vaccination
1
2016
266
0.030
Why?
In Situ Hybridization, Fluorescence
1
2015
259
0.030
Why?
Multivariate Analysis
1
2015
577
0.030
Why?
Anti-Bacterial Agents
1
2019
744
0.030
Why?
Genes, erbB-1
1
2013
8
0.030
Why?
Lipid Metabolism
1
2014
175
0.030
Why?
Gene Frequency
1
2013
94
0.030
Why?
Adiposity
1
2014
127
0.030
Why?
SEER Program
1
2013
94
0.030
Why?
Communication
1
2015
246
0.030
Why?
Mesentery
1
2012
32
0.030
Why?
Rural Health Services
1
2015
166
0.030
Why?
Research Design
1
2015
344
0.030
Why?
Insulin Resistance
1
2014
264
0.030
Why?
Vascular Endothelial Growth Factor Receptor-3
1
2012
5
0.030
Why?
Pregnancy Proteins
1
2012
5
0.030
Why?
Vascular Endothelial Growth Factor Receptor-1
1
2012
6
0.030
Why?
Neoplasms, Glandular and Epithelial
1
2012
42
0.030
Why?
Angiopoietin-2
1
2012
15
0.030
Why?
Diet, High-Fat
1
2014
222
0.030
Why?
Angiopoietin-1
1
2012
16
0.030
Why?
Socioeconomic Factors
1
2015
581
0.030
Why?
Ovary
1
2012
104
0.030
Why?
Ivermectin
1
2012
9
0.030
Why?
Antiparasitic Agents
1
2012
10
0.030
Why?
Vascular Endothelial Growth Factor Receptor-2
1
2012
32
0.030
Why?
Infant
1
2020
3567
0.030
Why?
Algorithms
1
2015
615
0.020
Why?
Hydatidiform Mole
1
2011
2
0.020
Why?
RNA, Messenger
1
2014
1105
0.020
Why?
Crohn Disease
1
2012
90
0.020
Why?
Isoenzymes
1
2011
168
0.020
Why?
Interleukin-6
1
2012
264
0.020
Why?
Promoter Regions, Genetic
1
2012
475
0.020
Why?
Gene Expression
1
2012
609
0.020
Why?
Risk Assessment
1
2015
1259
0.020
Why?
Radiography
1
2011
489
0.020
Why?
Cell Line
1
2012
1000
0.020
Why?
Cohort Studies
1
2013
1422
0.020
Why?
DNA Methylation
1
2012
548
0.020
Why?
Rats
1
2014
3305
0.020
Why?
Blotting, Western
1
2006
601
0.020
Why?
Myocardium
1
2006
436
0.010
Why?
Age Factors
1
2006
1087
0.010
Why?
Quick's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description